The licensing agreements you mention in every news release, why are these licensing partners not the ones working and providing funding to bring RECAF to market? Don't these companies have a lot to gain by bring this technology to the market place. Why is RECAF not in the market place now. Is it money, if so how much more is needed. Is it the science, if so what is left to validate?Is it time, how much longer must we wait?

You contine to state there is little or no work left to be done to bring a product to the market place. If that is true, why don't Abbott Laboratories and with Inverness Medical Innovations want RECAF as one of their products in the market place. Why isn't RECAF generating revenue. What is left to do? What is the company doing about what needs to be done?

Equity money is now flowing, markets have thawed, deals are being done and there must be a company that could use this alleged technology. Have you misrepresented the science or technology? Have the licensees lost faith in you and or RECAF?

Is RECAF a financally viable product? What is the market place, what is the size of the market place and who and how will it be marketed.

Where are we and where are we going.

Thank you